Skip to main content

U.S. makes initial offers in Medicare drug price negotiations

By The New York Times  
   February 01, 2024

The medicines selected for negotiations are taken by millions of Americans to treat conditions like diabetes, cancer and heart disease.

Full story


Get the latest on healthcare leadership in your inbox.